Replies to post #181495 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Dr. Ashkan was talking about March 2017 data at that point, as you well know, he then goes on to state, at that ASCO, which occurred 15 months after the March 2017 data, that his position is to push toward unblinding, because it is the only real way to demonstrate efficacy impact.

[pennymonster1]

Bought 5 shares today, thanks for changing my mind.